Skip to main content

Autologous Exosome Therapy for Inflammation and Tissue Repair

Discover Autologous Exosomes, an ultra-concentrated, cell-free regenerative solution derived from your patient’s own blood, designed to reduce inflammation and accelerate healing.

Patient-Centered Regeneration, Backed by Science

Autologous exosome therapy that uses your patient’s own blood to isolate billions of bioactive proteins, microRNAs, and growth factors. With ultra-high purity and consistent potency that supports the body’s natural healing processes at the cellular level—without the risks of PRP or synthetic biologics.

blue dna.png

Why Providers Choose Autologous Exosomes

  • Ultra-High Exosome Concentration

    400–600 billion exosomes per mL—more than typical PRP

  • 100% Autologous

    Derived from the patient’s own blood for natural compatibility

  • Acellular and Additive-Free

    No platelets, cells, cryoprotectants, or synthetic compounds

  • Minimal Risk of Reaction

    No cellular debris or immune-triggering components

  • Standardized and Predictable

    Proprietary processing ensures consistent therapeutic results

  • Rapid, In-Office Procedure

    Easy integration with no downtime for patients

Innovative Solutions for Better Health Outcomes

A. Mechanism of Action

Exosomes act as molecular messengers, delivering microRNAs, proteins, and growth factors directly to damaged tissues. This helps reduce inflammation, support cellular regeneration, and improve tissue function.

B. Clinical Use Cases

Autologous Exosomes is used across regenerative disciplines:

  • Orthopedics (knee osteoarthritis, tendon injuries)
  • Aesthetics (skin rejuvenation, hair loss)
  • Sexual wellness
  • Long COVID and systemic inflammation
  • Sports medicine and rehabilitation
istock-1150397417.jpg

Why Choose Autologous Exosomes Over PRP?
  • Exosomes are acellular. PRP is not.
  • Exosomes are standardized. PRP is highly variable.
  • Exosomes contain targeted microRNA. PRP contains mixed platelets.
  • Exosomes reduce inflammation predictably. PRP responses vary.
dna image.png

Backed by Research, Driven by Results**
  • 14 completed Phase 1 clinical trials
  • 5 FDA-approved INDs (e.g., knee OA, long COVID)
  • Published data showing reduced inflammation and enhanced healing

Autologous Exosomes delivers a level of purity and consistency we’ve never seen in traditional biologics.”

scientist-conducting-research-in-modern-laboratory-2025-05-17-22-32-12-utc.jpg

Advanced Processing for Maximum Purity

Autologous Exosomes is manufactured using a proprietary, high-speed centrifugation method that isolates the most bioactive exosomal fraction from whole blood—without introducing cells or contaminants. All processing occurs in an FDA-registered, cGMP-compliant lab to ensure unmatched safety and quality.

person-presenting-a-3d-render-of-cloud-computing-e-2025-02-06-04-01-53-utc.jpg

Simple to Offer. Easy to Implement.**

3-Step Process:

Frequently Asked Questions

Expert insights on wound care solutions

  • Unlike PRP, which contains a mixture of platelets and can vary in concentration, Autologous Exosomes delivers a cell-free, highly concentrated exosome formulation—400–600 billion exosomes per mL—produced through a standardized, patent-pending process. Unlike stem cell therapies, uses the patient’s own blood and contains no live cells, eliminating the risk of immune reaction or regulatory complications.

  • Yes. Because it’s 100% autologous and acellular, Autologous Exosomes significantly reduces the risk of immune response, inflammation, or complications. It contains no additives, cryoprotectants, or synthetic materials.

  • Autologous Exosomes supports healing and regeneration in a wide range of conditions, including:

    • Knee osteoarthritis
    • Muscle and tendon injuries
    • Hair loss (androgenic alopecia)
    • Sexual dysfunction
    • Aesthetic skin rejuvenation
    • Long COVID-related inflammation

Bring Autologous Exosomes to Your Practice
Have questions? Our team is here to help you explore how Autologous Exosomes fits your patient care model and clinical goals.